RESEARCH OVERVIEW
We have brought together a diverse group of investigators from basic science and clinical medicine, with combined expertise in virology, immunology, liver disease and transplantation, genomics, proteomics, bioinformatics, biostatistics, and technology development; this includes more than 20 key personnel and over 20 collaborators from over a dozen academic institutions and three corporations. This confluence of basic science and clinical medicine, together with genomic, proteomic, and information technologies, represents an unparalleled opportunity to make advances in our understanding HCV-associated liver disease, AIDS, and HCV/HIV-1 dual infection.
Watch the NIDA Center video (Windows Media format).
Funding for the Center is provided by the National Institute on Drug Abuse (P30 DA015625), the National Institute of Allergy and Infectious Diseases, the National Institute of Diabetes and Digestive and Kidney Diseases, and the U.S. Department of Energy.